On 1/15/25, Evolent Health Inc (NYSE: EVH) stock suffered a major decline of -10.8%, closing at $9.97. Moreover, trading volume in this decline was exceptionally high at 227% of normal. The stock has declined -16.9% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Evolent Health has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Evolent Health has a good Appreciation Score of 75 but a slightly negative Power Rating of 30, and the Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment